206 related articles for article (PubMed ID: 15231579)
21. Identification of an immunogenic CTL epitope of HIFPH3 for immunotherapy of renal cell carcinoma.
Sato E; Torigoe T; Hirohashi Y; Kitamura H; Tanaka T; Honma I; Asanuma H; Harada K; Takasu H; Masumori N; Ito N; Hasegawa T; Tsukamoto T; Sato N
Clin Cancer Res; 2008 Nov; 14(21):6916-23. PubMed ID: 18980986
[TBL] [Abstract][Full Text] [Related]
22. Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein.
Van Epps HL; Schmaljohn CS; Ennis FA
J Virol; 1999 Jul; 73(7):5301-8. PubMed ID: 10364276
[TBL] [Abstract][Full Text] [Related]
23. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
Stevens EJ; Jacknin L; Robbins PF; Kawakami Y; el Gamil M; Rosenberg SA; Yannelli JR
J Immunol; 1995 Jan; 154(2):762-71. PubMed ID: 7814882
[TBL] [Abstract][Full Text] [Related]
24. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
Carreno BM; Turner RV; Biddison WE; Coligan JE
J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response.
Bukur J; Malenica B; Huber C; Seliger B
Hum Immunol; 2003 Nov; 64(11):1081-92. PubMed ID: 14602239
[TBL] [Abstract][Full Text] [Related]
26. Isolation of broadly reactive, tumor-specific, HLA Class-I restricted CTL from blood lymphocytes of a breast cancer patient.
Verdegaal EM; Huinink DB; Hoogstraten C; Marijnissen AK; Gorsira MB; Claas FH; Osanto S
Hum Immunol; 1999 Dec; 60(12):1195-206. PubMed ID: 10626733
[TBL] [Abstract][Full Text] [Related]
27. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
[TBL] [Abstract][Full Text] [Related]
28. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.
Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL
J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821
[TBL] [Abstract][Full Text] [Related]
29. The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes.
Vissers JL; De Vries IJ; Schreurs MW; Engelen LP; Oosterwijk E; Figdor CG; Adema GJ
Cancer Res; 1999 Nov; 59(21):5554-9. PubMed ID: 10554034
[TBL] [Abstract][Full Text] [Related]
30. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
31. CD4+ and CD8+ T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes. Implications for HLA class I and II allelic linkage to disease susceptibility.
Ou D; Jonsen LA; Metzger DL; Tingle AJ
Hum Immunol; 1999 Aug; 60(8):652-64. PubMed ID: 10439311
[TBL] [Abstract][Full Text] [Related]
32. Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity.
Amrolia PJ; Reid SD; Gao L; Schultheis B; Dotti G; Brenner MK; Melo JV; Goldman JM; Stauss HJ
Blood; 2003 Feb; 101(3):1007-14. PubMed ID: 12393606
[TBL] [Abstract][Full Text] [Related]
33. Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.
Hofmann S; Glückmann M; Kausche S; Schmidt A; Corvey C; Lichtenfels R; Huber C; Albrecht C; Karas M; Herr W
Mol Cell Proteomics; 2005 Dec; 4(12):1888-97. PubMed ID: 16112985
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
Vandekerckhove BA; Datema G; Koning F; Goulmy E; Persijn GG; Van Rood JJ; Claas FH; De Vries JE
J Immunol; 1990 Feb; 144(4):1288-94. PubMed ID: 2137487
[TBL] [Abstract][Full Text] [Related]
35. Identification of melanoma-specific peptide epitopes by HLA-A2.1-restricted cytotoxic T lymphocytes.
Ge HL; Wang Y; Wang SJ; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2006 Feb; 38(2):110-8. PubMed ID: 16474902
[TBL] [Abstract][Full Text] [Related]
36. CD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft model.
Tykodi SS; Satoh S; Deming JD; Chou J; Harrop R; Warren EH
J Immunother; 2012 Sep; 35(7):523-33. PubMed ID: 22892449
[TBL] [Abstract][Full Text] [Related]
37. Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.
Frankenberger B; Pohla H; Noessner E; Willimsky G; Papier B; Pezzutto A; Kopp J; Oberneder R; Blankenstein T; Schendel DJ
Clin Cancer Res; 2005 Mar; 11(5):1733-42. PubMed ID: 15755994
[TBL] [Abstract][Full Text] [Related]
38. Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine.
Shawler DL; Bartholomew RM; Garrett MA; Trauger RJ; Dorigo O; Van Beveren C; Marchese A; Ferre F; Duffy C; Carlo DJ; Sherman LA; Gold DP; Sobol RE
Clin Exp Immunol; 2002 Jul; 129(1):99-106. PubMed ID: 12100028
[TBL] [Abstract][Full Text] [Related]
39. Human CD8 and CD4 T cell epitopes of epithelial cancer antigens.
Sato N; Nabeta Y; Kondo H; Sahara H; Hirohashi Y; Kashiwagi K; Kanaseki T; Sato Y; Rong S; Hirai I; Kamiguchi K; Tamura Y; Matsuura A; Takahashi S; Torigoe T; Ikeda H
Cancer Chemother Pharmacol; 2000; 46 Suppl():S86-90. PubMed ID: 10950155
[TBL] [Abstract][Full Text] [Related]
40. Renal cell carcinoma-associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen-DR molecules to CD4(+) T lymphocytes.
Vissers JL; De Vries IJ; Engelen LP; Scharenborg NM; Molkenboer J; Figdor CG; Oosterwijk E; Adema GJ
Int J Cancer; 2002 Aug; 100(4):441-4. PubMed ID: 12115527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
